Durable Response of Metastatic Squamous Cell Carcinoma of the Skin to Ipilimumab Immunotherapy

被引：28
|
作者：
Day, Fiona [1 ,2 ]
Kumar, Mahesh [1 ,2 ]
Fenton, Linda [1 ]
Gedye, Craig [1 ,3 ]
机构：
[1] Calvary Mater Newcastle, Waratah, NSW, Australia
[2] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia
[3] Univ Newcastle, Sch Biomed Sci & Pharm, Hunter Med Res Inst, New Lambton Hts, NSW, Australia
来源：
JOURNAL OF IMMUNOTHERAPY | 2017年 / 40卷 / 01期
关键词：
squamous cell carcinoma of skin; immunotherapy; checkpoint inhibitor; ipilimumab; MALIGNANCIES;
D O I：
10.1097/CJI.0000000000000146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A 72-year-old male patient was receiving second-line chemotherapy for metastatic squamous cell carcinoma of the skin (SCCS) when he was diagnosed with concurrent metastatic melanoma (BRAF(G469E) mutant). Chemotherapy was ceased and he was treated with 4 cycles of ipilimumab immunotherapy. The patient experienced clinical benefit and durable remission in both malignancies and remains free of cancer progression 8 months after the last cycle of ipilimumab. Response of SCCS to ipilimumab has not been previously described, however this case and recent reports of pembrolizumab efficacy confirm the critical role of the immune system in SCCS pathogenesis and suggest further exploration of checkpoint immunotherapy for the treatment of this disease.
引用
收藏
页码：36 / 38
页数：3
相关论文
共 50 条
  • [31] Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Lasniska, Izabela
    Kolenda, Tomasz
    Teresiak, Anna
    Lamperska, Katarzyna M.
    Galus, Lukasz
    Mackiewicz, Jacek
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 290 - 303
  • [32] Tumor Histological Grade and Immunotherapy Response in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Alkhatib, Hosam H.
    Maroun, Christopher A.
    Amin, Neha
    Zhu, Gangcai
    Guller, Meytal
    Herberg, Matthew E.
    Wu, Evan S.
    Seiwert, Tanguy Y.
    Rooper, Lisa M.
    Eisele, David W.
    Fakhry, Carole
    Pardoll, Drew
    Mandal, Rajarsi
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 148 (06) : 540 - 546
  • [33] Durable Response to Carboplatin, Etoposide, Nivolumab, and Ipilimumab in Metastatic High-Grade Neuroendocrine Carcinoma of the Gallbladder
    Chorath, Jeena
    Placencio-Hickok, Veronica R.
    Guan, Michelle
    Nissen, Nicholas
    Kamrava, Mitchell
    Klempner, Samuel J.
    Nassir, Youram
    Hendifar, Andrew
    Gong, Jun
    PANCREAS, 2020, 49 (02) : E19 - E20
  • [34] Microbiome modulates immunotherapy response in cutaneous squamous cell carcinoma
    Voigt, Anita Y.
    Walter, Andrew
    Young, Timothy H.
    Graham, John P.
    Bittencourt, Bruna Batista M.
    Pulido, Alvaro de Mingo
    Prieto, Karol
    Tsai, Kenneth Y.
    Sundberg, John P.
    Oh, Julia
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (10) : 1624 - 1632
  • [35] Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma of the Head and Neck
    Klein, Oliver
    JAMA ONCOLOGY, 2024, 10 (01) : 143 - 144
  • [36] Durable response to combination immunotherapy using nivolumab and ipilimumab in metastatic succinate dehydrogenase (SDH)-deficient gastrointestinal stroma tumour
    Klein, Oliver
    Palmer, Jodie
    Behren, Andreas
    Cebon, Jonathan
    Kee, Damien
    EUROPEAN JOURNAL OF CANCER, 2023, 194
  • [37] Durable complete response rates following radiotherapy and immunotherapy combination in recurrent and metastatic head and neck squamous cell carcinoma: A retrospective single-centre cohort study
    Khera, Raj
    Feeney, Laura
    Swinton, Martin
    Rack, Samuel
    Sykes, Andrew
    Metcalf, Robert
    CLINICAL OTOLARYNGOLOGY, 2022, 47 (05) : 606 - 610
  • [38] Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab
    Chahoud, Jad
    Skelton, William Paul
    Spiess, Philippe E.
    Walko, Christine
    Dhillon, Jasreman
    Gage, Kenneth L.
    Johnstone, Peter A. S.
    Jain, Rohit K.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [39] Metastatic papillary renal cell carcinoma - Is there any response to immunotherapy?
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 232 - 232
  • [40] SQUAMOUS-CELL CARCINOMA OF THE MAXILLARY ANTRUM METASTATIC TO THE HEART AND SKIN
    CALVERT, RJ
    QUINN, CM
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1994, 108 (10): : 896 - 897
12345